MARIAN MIZELLE: Open Payments
NPI 1205578242 · DANVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,776 in 134 payments from 20 companies in 2025. Trend: 2023 $4,005 · 2024 $3,654 · 2025 $2,776
Food & beverage: $2,550Education: $226
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $581 |
| Janssen Biotech, Inc. | 21 | $459 |
| UCB, Inc. | 11 | $307 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 17 | $287 |
| GENZYME CORPORATION | 11 | $200 |
| Novartis Pharmaceuticals Corporation | 8 | $179 |
| Regeneron Healthcare Solutions, Inc. | 9 | $154 |
| LEO Pharma Inc. | 4 | $98 |
| Organon LLC | 4 | $95 |
| Galderma Laboratories, L.P. | 4 | $83 |
Products named: TREMFYA, DUPIXENT, Bimzelx, SKYRIZI, RINVOQ, COSENTYX, ILUMYA, NEMLUVIO.
Industry payments across VA — which companies pay providers there.
